Trends in Pharmacological Sciences 1998 - Abstracts
| Trends in Pharmacological Sciences 1998 | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Adenosine and ATP: progress in their receptors' structures and functions. (adenosine triphosphate) | Pharmaceuticals and cosmetics industries | Khakh, Baljit S., Kennedy, Charles | |||
| Agneter et al. reply.(response to article by Jesus Giraldo in this issue, p. 445) | Pharmaceuticals and cosmetics industries | Agneter, E., Singer, E.A., Sauermann, W., Feuerstein, T.J. | |||
| An approach to the development of novel antihypertensive drugs: Potential role of sodium pump inhibitors. | Pharmaceuticals and cosmetics industries | Goto, Atsuo, Yamada, Kaoru | |||
| A new role for catecholamines: ontogenesis. | Pharmaceuticals and cosmetics industries | Pendleton, Robert G., Rasheed, Aseel, Roychowdhury, Rupanjali, Hillman, Ralph | |||
| An orange a day keeps the scurvy away. (vitamin C) | Pharmaceuticals and cosmetics industries | Manchester, Keith L. | |||
| Asthma therapy for the 21st century. | Pharmaceuticals and cosmetics industries | Rogers, Duncan F., Giembycz, Mark A. | |||
| ATP-sensitive K+ channels come of age.(adenosine triphosphate; potassium) | Pharmaceuticals and cosmetics industries | Cook, Daniel L., Bryan, Joseph | |||
| Ca2+ channel block and inactivation: common molecular determinants. | Pharmaceuticals and cosmetics industries | Hering, Steffen, Berjukow, Stanislav, Aczel, Stefan, Timin, Eugen N. | |||
| Calcitonin gene-related peptide - a new concept in receptor-ligand specificity? | Pharmaceuticals and cosmetics industries | Smith, David M., Hall, Judith M. | |||
| Cytochrome P450 in the brain: 2B or not 2B. | Pharmaceuticals and cosmetics industries | Gustafsson, Jan-Ake, Hedlund, Eva, Warner, Margaret | |||
| Dizocilpine (MK801): use or abuse? | Pharmaceuticals and cosmetics industries | Vanderschuren, Louk J.M.J, Schoffelmeer, Anton N.M., Mulder, Arie H., Vries, Taco J. | |||
| Endothelin: new discoveries and rapid progress in the clinic. | Pharmaceuticals and cosmetics industries | Yanagisawa, Masashi, Webb, David J., Monge, Juan C., Rabelink, Ton J. | |||
| Evidence for multiple biochemically distinguishable states in the G protein-coupled receptor, rhodopsin. | Pharmaceuticals and cosmetics industries | Surya, Arjun, Stadel, Jeffrey M., Knox, Barry E. | |||
| Frizzled proteins constitute a novel family of G protein-coupled receptors, most closely related to the secretin family. | Pharmaceuticals and cosmetics industries | Beeley, Lee J., Barnes, Michael R., Duckworth, D. Malcolm | |||
| Genomics and drug discovery. | Pharmaceuticals and cosmetics industries | Van Oosterhout, Antoon J.M. | |||
| Handy and Moore reply. (response to an article by Anton Reiner and Yuri Zagvazdin in this issue, p. 348) | Pharmaceuticals and cosmetics industries | Handy, Rachel L.C., Moore, Philip K. | |||
| Involvement of T cells in drug-induced allergies. | Pharmaceuticals and cosmetics industries | Zanni, Martin P., Schnyder, Benno, von Greyerz, Salome, Pichler, Werner J. | |||
| Isoforms of endothelin-converting enzyme: why and where? | Pharmaceuticals and cosmetics industries | Turner, Anthony J., Barnes, Kay, Schweizer, Anja, Valdenaire, Olivier | |||
| Langer et al. reply. (response to article by Pierre M. Laduron in this issue, p.127) | Pharmaceuticals and cosmetics industries | Langer, Salomon Z., Scatton, B., Schoemaker, H., Rein, W. | |||
| Mark Nickerson (1916-1998).(pharmacologist)(Obituary) | Pharmaceuticals and cosmetics industries | Cuello, A. Claudio | |||
| Menek Goldstein (1926-1997).(Obituary) | Pharmaceuticals and cosmetics industries | Fuxe, Kjell, Hokkfelt, Tomas | |||
| Modulation of intracellular Ca2+ levels in the heart by sorcin and FKBP12, two accessory proteins of ryanodine receptors. | Pharmaceuticals and cosmetics industries | Valdivia, Hector H. | |||
| Multiple P2 receptor subtypes on platelets: a new interpretation of their function. | Pharmaceuticals and cosmetics industries | Kunapuli, Satya P. | |||
| Neurone development and death, from a cell biologist's perspective. | Pharmaceuticals and cosmetics industries | Gibson, Rosemary M. | |||
| Neuropeptides and nociception: recent advances and therapeutic implications. | Pharmaceuticals and cosmetics industries | Fleetwood-Walker, Susan M., Dickinson, Tracey | |||
| New delta-opioid antagonists as pharmacological probes. (includes related article on opioid receptors and opioid ligands) | Pharmaceuticals and cosmetics industries | Bryant, Sharon D., Salvadori, Severo, Cooper, Peter S., Lazarus, Lawrence H. | |||
| Nitric oxide: from discovery to the clinic. | Pharmaceuticals and cosmetics industries | Lamas, Santiago, Moncada, Salvador, Perez-Sala, Dolores | |||
| Novel tools for localizing ion channels in living cells. | Pharmaceuticals and cosmetics industries | Nichols, Colin G., Lopatin, Anatoli N., Makhina, Elena N. | |||
| On the presence of a putative fourth beta-adrenoceptor in human adipose tissue. | Pharmaceuticals and cosmetics industries | Langin, Dominique, Montastruc, Jean-Louis, Berlan, Michel, Lafontan, Max, Galitzky, Jean | |||
| On the selectivity of 7-nitroindazole as an inhibitor of neuronal nitric oxide synthase. (response to Rachel L.C. Handy and Philip K. Moore, in the Trends in Pharmacological Sciences, vol. 18, p. 204, 1996) | Pharmaceuticals and cosmetics industries | Reiner, Anton, Zagvazdin, Yuri | |||
| Peptide G protein-coupled receptors at Erice. (highlights of a conference on clinical and research developments on peptide G protein-coupled receptors held in Erice, Italy) | Pharmaceuticals and cosmetics industries | Bouvier, Michel, Bunnett, Nigel W., Blasi, Antonio De | |||
| Pharmacology in Germany. | Pharmaceuticals and cosmetics industries | Trendelenburg, Ullrich | |||
| P/Q-type Ca2+ channel defects in migraine, ataxia and epilepsy. | Pharmaceuticals and cosmetics industries | Terwindt, Gisela M., Ophoff, Roel A., Frants, Rune R., Ferrari, Michael D. | |||
| Presynaptic receptors: more hetero than auto. (response to article by Salomon Z. Langer et al, Trends in Pharmacological Sciences, vol. 18, p. 95) | Pharmaceuticals and cosmetics industries | Laduron, Pierre M. | |||
| Principles of agonism: undressing efficacy. | Pharmaceuticals and cosmetics industries | Schwartz, Thue W., IJzerman, Ad P. | |||
| Receptor targets in William Tell country: insights into receptor biology using fluorescent proteins. | Pharmaceuticals and cosmetics industries | Mills, Ann | |||
| Sparks of interest in cardiac excitation-contraction coupling. | Pharmaceuticals and cosmetics industries | Cannell, Mark B., Soeller, Christian | |||
| Strategies and technologies for drug delivery systems. | Pharmaceuticals and cosmetics industries | Jain, Kewal K. | |||
| Strosberg et al. reply. (response to article by Jean Galitzky et. al., in this issue, p. 164) | Pharmaceuticals and cosmetics industries | Strosberg, A. Donny, Gros, Jerome, Gerhardt, Cindy C., Jockers, Ralf, Pietri-Rouxel, France | |||
| The future of pharmacology. (strategies in drug development) | Pharmaceuticals and cosmetics industries | Lohse, Martin J. | |||
| The slope parameter and the receptor reserve.(response to article by E. Agneter, E.A. Singer, W. Sauermann and T.J. Feuerstein, Naunyn-Schmiedeberg's Arch. Pharmacology, vol 356) | Pharmaceuticals and cosmetics industries | Giraldo, Jesus | |||
| The structure and signalling properties of 5-HT receptors: an endless diversity? | Pharmaceuticals and cosmetics industries | Eglen, Richard M., Martin, Graeme R., Hamblin, Mark W., Hoyer, Daniel, Yocca, Frank | |||
| Use of pharmacological agents in elucidating the mechanism of insulin action. | Pharmaceuticals and cosmetics industries | Srivastava, Ashok K. | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.